Celgene raises $2.5 billion in note deal

Celgene Corp. (NASDAQ:CELG) raised $2.5 billion through the sale of senior unsecured notes. The notes comprise $500 million in 2.25% notes due 2019; $1 billion in 3.625% notes due 2024; and $1 billion in 4.625% notes due 2044. The company said it plans to use the proceeds for general corporate purposes. Merrill Lynch; Credit Suisse; Goldman Sachs; and Morgan Stanley are book-running managers. ...